BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9663462)

  • 21. The Hypothalamic-Pituitary-Adrenal Axis and Serotonin Metabolism in Individual Brain Nuclei of Mice with Genetic Disruption of the NK1 Receptor Exposed to Acute Stress.
    Culman J; Mühlenhoff S; Blume A; Hedderich J; Lützen U; Hunt SP; Rupniak NMJ; Zhao Y
    Cell Mol Neurobiol; 2018 Aug; 38(6):1271-1281. PubMed ID: 29948553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ewes With Divergent Cortisol Responses to ACTH Exhibit Functional Differences in the Hypothalamo-Pituitary-Adrenal (HPA) Axis.
    Hewagalamulage SD; Clarke IJ; Rao A; Henry BA
    Endocrinology; 2016 Sep; 157(9):3540-9. PubMed ID: 27414744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin stimulates CRH and ACTH release by rat adrenal medulla in vitro.
    Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo G; Nussdorfer GG
    Neuropeptides; 1997 Feb; 31(1):8-11. PubMed ID: 9574829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the hypothalamic-pituitary-adrenal axis.
    Papadimitriou A; Priftis KN
    Neuroimmunomodulation; 2009; 16(5):265-71. PubMed ID: 19571587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuromedin U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis. Evidence of a direct effect of NMU-8 on the adrenal gland.
    Malendowicz LK; Nussdorfer GG; Markowska A; Tortorella C; Nowak M; Warchol JB
    Neuropeptides; 1994 Jan; 26(1):47-53. PubMed ID: 8159286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis.
    Fernandez PM; Brunel F; Jimenez MA; Saez JM; Cereghini S; Zakin MM
    Endocrinology; 2000 Jul; 141(7):2392-400. PubMed ID: 10875239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats.
    Zelena D; Domokos A; Barna I; Mergl Z; Haller J; Makara GB
    Endocrinology; 2008 May; 149(5):2576-83. PubMed ID: 18276753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of HPAA in Different Rat Models of Gan Stagnation, Pi Deficiency, Gan Stagnation Pi Defi- ciency and Interventional Effect of Chaishu Sijun Decoction].
    Zhao RH; Liu JN; Li C; Zhang JS; Wang BZ; Yao YC; Xie M; Wang DH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul; 35(7):834-8. PubMed ID: 26380447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
    Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol.
    Ito N; Ito T; Kromminga A; Bettermann A; Takigawa M; Kees F; Straub RH; Paus R
    FASEB J; 2005 Aug; 19(10):1332-4. PubMed ID: 15946990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.
    Beishuizen A; Thijs LG
    J Endotoxin Res; 2003; 9(1):3-24. PubMed ID: 12691614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hypothalamo-pituitary-adrenal axis of athymic Swiss nude mice. The implications of T lymphocytes in the ACTH release from immune cells.
    Gaillard RC; Daneva T; Hadid R; Muller K; Spinedi E
    Ann N Y Acad Sci; 1998 May; 840():480-90. PubMed ID: 9629274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
    Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
    Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.